Low-density lipoprotein cholesterol in patients with stable coronary heart disease - Is it time to shift our goals?

被引:38
作者
Pitt, B [1 ]
机构
[1] Univ Michigan, Sch Med, Ann Arbor, MI 48104 USA
关键词
D O I
10.1056/NEJMe058052
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
引用
收藏
页码:1483 / 1484
页数:2
相关论文
共 7 条
[1]
Intensive versus moderate lipid lowering with statins after acute coronary syndromes [J].
Cannon, CP ;
Braunwald, E ;
McCabe, CH ;
Rader, DJ ;
Rouleau, JL ;
Belder, R ;
Joyal, SV ;
Hill, KA ;
Pfeffer, MA ;
Skene, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) :1495-1504
[3]
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines [J].
Grundy, SM ;
Cleeman, JI ;
Merz, CNB ;
Brewer, HB ;
Clark, LT ;
Hunninghake, DB ;
Pasternak, RC ;
Smith, SC ;
Stone, NJ .
CIRCULATION, 2004, 110 (02) :227-239
[4]
Intensive lipid lowering with atorvastatin in patients with stable coronary disease [J].
LaRosa, JC ;
Grundy, SM ;
Waters, DD ;
Shear, C ;
Barter, P ;
Fruchart, J ;
Gotto, AM ;
Greten, H ;
Kastelein, JJP ;
Shepherd, J ;
Wenger, NK .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (14) :1425-1435
[5]
Lipka LJ, 2003, CARDIOVASC DRUG REV, V21, P293
[6]
High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study [J].
Walldius, G ;
Jungner, I ;
Holme, I ;
Aastveit, AH ;
Kolar, W ;
Steiner, E .
LANCET, 2001, 358 (9298) :2026-2033
[7]
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study [J].
Yusuf, S ;
Hawken, S ;
Ounpuu, S ;
Dans, T ;
Avezum, A ;
Lanas, F ;
McQueen, M ;
Budaj, A ;
Pais, P ;
Varigos, J ;
Liu, LS .
LANCET, 2004, 364 (9438) :937-952